Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA to review if new 'effects table' for drugs helps HTA bodies in their work

This article was originally published in SRA

Executive Summary

The European Medicines Agency is to ascertain whether the recent introduction of the "effects table" in its assessment reports for drugs is helpful to health technology assessment bodies carrying out relative effectiveness assessments of drugs.

Advertisement
Advertisement
UsernamePublicRestriction

Register